It was reported that the natural auto-antibodies against CS (anti-CS IgM and IgG antibodies) were increased in rheumatoid arthritis (RA) patients treated with TNF inhibitors, certolizumab or etanercept therapy [30]. The gene discussed is CD40LG; the disease is rheumatoid arthritis.